Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022 – 2033
2.3 Market Size & Forecast, By Segmentation, 2022 – 2033
2.3.1 Market Size By Product
2.3.2 Market Size By Application
2.3.3 Market Size By Method
2.3.4 Market Size By End-Use
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Plasma Collection & Donor Metrics
4.1.1 Overview
4.1.2 Number of Plasma Donors by Region
4.1.3 % of Voluntary vs. Paid Donors
4.1.4 Average Plasma Volume Collected per Donor (Liters/Year)
4.1.5 Growth Rate of Plasma Donation Centers (YoY)
4.2 Fractionation & Production Metrics
4.2.1 Overview
4.2.2 Average Yield of Plasma Proteins per Liter of Plasma
4.2.3 % of Plasma Processed for Immunoglobulins, Albumin, Clotting Factors
4.2.4 Batch Success / Rejection Rate (%)
4.2.5 Adoption Rate of Modern Fractionation Technologies (Cohn, Chromatography, Filtration)
4.3 Supply Chain & Inventory Metrics
4.3.1 Overview
4.3.2 Average Inventory Turnover of Plasma Products (Days)
4.3.3 % of Plasma Products Stored under Cold Chain Compliance
4.3.4 Lead Time for Product Delivery by Region (Days)
4.3.5 Regional Distribution Share of Plasma Products (%)
4.4 Regulatory & Safety Metrics
4.4.1 Overview
4.4.2 % Compliance with FDA, EMA, WHO Guidelines
4.4.3 Number of Reported Adverse Events per Million Units
4.4.4 Rate of Plasma Product Recalls (%)
4.4.5 Average Time for Regulatory Approvals for New Plasma Products (Months)
5. Plasma Fractionation Market Segmental Analysis & Forecast, By Product, 2022 – 2033, Value (USD Billion)
5.1 Introduction
5.2 Albumin
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2033
5.3 Immunoglobulins
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2022 – 2033
5.3.7 Intravenous immunoglobulins
5.3.8 Subcutaneous immunoglobulins
5.3.9 Others
5.4 Coagulation Factors
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2022 – 2033
5.4.7 Factor VIII
5.4.8 Factor IX
5.4.9 VON WILLEBRAND factor
5.4.7 Prothrombin complex concentrates
5.4.8 Fibrinogen concentrates
5.4.9 Others
5.5 Protease inhibitors
5.6 Others
6. Plasma Fractionation Market Segmental Analysis & Forecast, By Application, 2022 – 2033, Value (USD Billion)
6.1 Introduction
6.2 Neurology
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2033
6.3 Hematology
6.4 Oncology
6.5 Immunology
6.6 Pulmonology
6.7 Others
7. Plasma Fractionation Market Segmental Analysis & Forecast, By Method, 2022 – 2033, Value (USD Billion)
7.1 Introduction
7.2 Centrifugation
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2033
7.3 Depth Filtration
7.4 Chromatography
7.5 Others
8. Plasma Fractionation Market Segmental Analysis & Forecast, By End-Use, 2022 – 2033, Value (USD Billion)
8.1 Introduction
8.2 Hospitals & Clinics
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2033
8.3 Clinical Research
8.4 Others
9. Plasma Fractionation Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Plasma Fractionation Market Size & Forecast, By Product, 2022 – 2033
9.2.3 Plasma Fractionation Market Size & Forecast, By Application, 2022 – 2033
9.2.4 Plasma Fractionation Market Size & Forecast, By Method, 2022 – 2033
9.2.5 Plasma Fractionation Market Size & Forecast, By End-Use, 2022 – 2033
9.2.6 Plasma Fractionation Market Size & Forecast, By Country, 2022 – 2033
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Plasma Fractionation Market Size & Forecast, By Product, 2022 – 2033
9.3.3 Plasma Fractionation Market Size & Forecast, By Application, 2022 – 2033
9.3.4 Plasma Fractionation Market Size & Forecast, By Method, 2022 – 2033
9.3.5 Plasma Fractionation Market Size & Forecast, By End-Use, 2022 – 2033
9.3.6 Plasma Fractionation Market Size & Forecast, By Country, 2022 – 2033
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Plasma Fractionation Market Size & Forecast, By Product, 2022 – 2033
9.4.3 Plasma Fractionation Market Size & Forecast, By Application, 2022 – 2033
9.4.4 Plasma Fractionation Market Size & Forecast, By Method, 2022 – 2033
9.4.5 Plasma Fractionation Market Size & Forecast, By End-Use, 2022 – 2033
9.4.6 Plasma Fractionation Market Size & Forecast, By Country, 2022 – 2033
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Plasma Fractionation Market Size & Forecast, By Product, 2022 – 2033
9.5.3 Plasma Fractionation Market Size & Forecast, By Application, 2022 – 2033
9.5.4 Plasma Fractionation Market Size & Forecast, By Method, 2022 – 2033
9.5.5 Plasma Fractionation Market Size & Forecast, By End-Use, 2022 – 2033
9.5.6 Plasma Fractionation Market Size & Forecast, By Country, 2022 – 2033
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Plasma Fractionation Market Size & Forecast, By Product, 2022 – 2033
9.6.3 Plasma Fractionation Market Size & Forecast, By Application, 2022 – 2033
9.6.4 Plasma Fractionation Market Size & Forecast, By Method, 2022 – 2033
9.6.5 Plasma Fractionation Market Size & Forecast, By End-Use, 2022 – 2033
9.6.6 Plasma Fractionation Market Size & Forecast, By Country, 2022 – 2033
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2024
10.2.2 Year-Wise Strategies & Development, 2021 – 2025
10.2.3 Number Of Strategies Adopted By Key Players, 2024
10.3 Market Share Analysis, 2024
10.4 Product/Service & Application Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Application Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 CSL Behring
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Grifols S.A.
10.6.3 Takeda Pharmaceutical Company Limited
10.6.4 Octapharma AG
10.6.5 Kedrion Biopharma Inc.
10.6.6 Bio Products Laboratory (BPL)
10.6.7 Sanquin
10.6.8 LFB S.A.
10.6.9 China Biologic Products Holdings Inc.
10.6.10 Green Cross Corporation (GC Pharma)
10.6.11 Syntegon
10.6.12 Hualan Bio
10.6.13 Intas Pharmaceuticals Ltd.
10.6.14 Biotest AG
10.6.15 Bio Products Laboratory Ltd. (BPL)
10.6.16 Shanghai RAAS Blood Products Co., Ltd.
10.6.17 Sanquin
10.6.18 Kamada Ltd.
10.6.19 Haemonetics Corporation
10.6.20 Mitsubishi Tanabe Pharma Corporation
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
